Page 49 - Contract Development News Today

/PRNewswire/ -- Evergreen Theragnostics has submitted a New Drug Application (NDA) for EVG-001 (Kit for preparation of Gallium-68 DOTATOC Injection), a...

/PRNewswire/ -- The "Biologics Contract Development Market Share, Size, Trends, Industry Analysis Report, By Source; By Indication; By Product Service; By...

/PRNewswire/ -- Goodwin Biotechnology, Inc. announces its new name, GBI, as part of a rebranding initiative to commemorate its 30-year anniversary. This...

/PRNewswire/ -- Goodwin Biotechnology, Inc. announces its new name, GBI, as part of a rebranding initiative to commemorate its 30-year anniversary. This...

/PRNewswire/ -- Goodwin Biotechnology, Inc. announces its new name, GBI, as part of a rebranding initiative to commemorate its 30-year anniversary. This...

/PRNewswire/ -- Goodwin Biotechnology, Inc. announces its new name, GBI, as part of a rebranding initiative to commemorate its 30-year anniversary. This...

Temporary and proactive suspension of prostaglandin production activities at the Budapest site following a routine internal assessment Prostaglandin products on the market are within specification

/PRNewswire/ -- In the fall of 2022, Jesse McCool, PhD, Founder and CEO and the Board of Directors of Wheeler Bio retained Life Science Partner to recruit...

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

PolyPeptide / Key word(s): Profit Warning/Personnel02-Dec-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Media Release – ad hoc announcement pursuant to Art. 53 LR PolyPeptide provides market updateBaar, 2 Decemb...